|
J. Biol. Chem., Vol. 265, Issue 17, 9732-9736, 06, 1990
Nucleoside transport in L1210 murine leukemia cells. Evidence for three transporters
CR Crawford, CY Ng, LD Noel and JA Belt
Department of Biochemical and Clinical Pharmacology, St. Jude Children's Research Hospital, Memphis, Tennessee 38101.
L1210 murine leukemia cells have two nucleoside transport activities that
differ in their sensitivity to nitrobenzylmercaptopurine riboside (NBMPR).
This study re-examines NBMPR-insensitive nucleoside transport in these
cells and finds that it is mediated by two components, one Na(+)-dependent
and the other Na(+)-independent. A mutant selected previously for loss of
NBMPR-insensitive transport lacks only the Na(+)- independent activity.
When NBMPR is used to block efflux via the NBMPR- sensitive transporter,
uptake of formycin B (a nonmetabolized analog of inosine) is concentrative
in both the parental and mutant cells, but the intracellular concentration
of the nucleoside is 5-fold lower in the parental cells. Decreased
accumulation of formycin B in the parental cells is due to efflux of the
nucleoside via the NBMPR- insensitive, Na(+)-independent transporter that
the mutant lacks. The Na(+)-dependent transporter appears to accept most
purine, but not pyrimidine, nucleosides as substrates. Two exceptions are
uridine, a good substrate, and 7-deazaadenosine, a poor substrate. In
contrast, all of the nucleosides tested are substrates for the
Na(+)-independent transporter. We conclude that L1210 cells have three
distinct nucleoside transporters and that the specificity of the
Na(+)-dependent transporter is similar to that of one of the two
Na(+)-dependent nucleoside transporters seen in mouse intestinal epithelial
cells.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
G. Lee, S. Dallas, M. Hong, and R. Bendayan
Drug Transporters in the Central Nervous System: Brain Barriers and Brain Parenchyma Considerations
Pharmacol. Rev.,
December 1, 2001;
53(4):
569 - 596.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. T. Lang, M. Selner, J. D. Young, and C. E. Cass
Acquisition of Human Concentrative Nucleoside Transporter 2 (hCNT2) Activity by Gene Transfer Confers Sensitivity to Fluoropyrimidine Nucleosides in Drug-Resistant Leukemia Cells
Mol. Pharmacol.,
November 1, 2001;
60(5):
1143 - 1152.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Xiao, J. Wang, T. Tangen, and K. M. Giacomini
A Novel Proton-Dependent Nucleoside Transporter, CeCNT3, from Caenorhabditis elegans
Mol. Pharmacol.,
February 1, 2001;
59(2):
339 - 348.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J. L. Ward, A. Sherali, Z.-P. Mo, and C.-M. Tse
Kinetic and Pharmacological Properties of Cloned Human Equilibrative Nucleoside Transporters, ENT1 and ENT2, Stably Expressed in Nucleoside Transporter-deficient PK15 Cells. ENT2 EXHIBITS A LOW AFFINITY FOR GUANOSINE AND CYTIDINE BUT A HIGH AFFINITY FOR INOSINE
J. Biol. Chem.,
March 17, 2000;
275(12):
8375 - 8381.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Hong, L. Schlichter, and R. Bendayan
A Na+-Dependent Nucleoside Transporter in Microglia
J. Pharmacol. Exp. Ther.,
January 1, 2000;
292(1):
366 - 374.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
R. W. Smith, D. F. Houlihan, G. E. Nilsson, and J. Alexandre
Tissue-specific changes in RNA synthesis in vivo during anoxia in crucian carp
Am J Physiol Regulatory Integrative Comp Physiol,
September 1, 1999;
277(3):
R690 - R697.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. E. Schaner, J. Wang, L. Zhang, S.-F. Su, K. M. Gerstin, and K. M. Giacomini
Functional Characterization of a Human Purine-Selective, Na+-Dependent Nucleoside Transporter (hSPNT1) in a Mammalian Expression System
J. Pharmacol. Exp. Ther.,
June 1, 1999;
289(3):
1487 - 1491.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
R. S. Mani, J. R. Hammond, J. M. J. Marjan, K. A. Graham, J. D. Young, S. A. Baldwin, and C. E. Cass
Demonstration of Equilibrative Nucleoside Transporters (hENT1 and hENT2) in Nuclear Envelopes of Cultured Human Choriocarcinoma (BeWo) Cells by Functional Reconstitution in Proteoliposomes
J. Biol. Chem.,
November 13, 1998;
273(46):
30818 - 30825.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Soler, A. Felipe, J. F. Mata, F. J. Casado, A. Celada, and M. Pastor-Anglada
Regulation of Nucleoside Transport by Lipopolysaccharide, Phorbol Esters, and Tumor Necrosis Factor-alpha in Human B-lymphocytes
J. Biol. Chem.,
October 9, 1998;
273(41):
26939 - 26945.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Burke, S. Lee, P. J. Ferguson, and J. R. Hammond
Interaction of 2',2'-Difluorodeoxycytidine (Gemcitabine) and Formycin B with the Na+-Dependent and -Independent Nucleoside Transporters of Ehrlich Ascites Tumor Cells
J. Pharmacol. Exp. Ther.,
September 1, 1998;
286(3):
1333 - 1340.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
S. A. Flanagan and K. A. Meckling-Gill
Characterization of a Novel Na+-dependent, Guanosine-specific, Nitrobenzylthioinosine-sensitive Transporter in Acute Promyelocytic Leukemia Cells
J. Biol. Chem.,
July 18, 1997;
272(29):
18026 - 18032.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. L. Borgl and a. F. E. Parkinson
Uptake and Release of [3H]Formycin B via Sodium-Dependent Nucleoside Transporters in Mouse Leukemic L1210/MA27.1 Cells
J. Pharmacol. Exp. Ther.,
April 1, 1997;
281(1):
347 - 353.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
D. L. Hogue, M. J. Ellison, J. D. Young, and C. E. Cass
Identification of a Novel Membrane Transporter Associated with Intracellular Membranes by Phenotypic Complementation in the Yeast Saccharomyces cerevisiae
J. Biol. Chem.,
April 19, 1996;
271(16):
9801 - 9808.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1990 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|